![Bob van Gemen](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Bob van Gemen
Directeur/Membre du Conseil chez Genome Diagnostics BV
Postes actifs de Bob van Gemen
Sociétés | Poste | Début | Fin |
---|---|---|---|
Genome Diagnostics BV
![]() Genome Diagnostics BV Medical SpecialtiesHealth Technology Genome Diagnostics BV develops and markets vitro diagnostic tests and services, analysis software & education. Its products include NGSengine, SBTexcellerator, AlleleSEQR and SBTengine. The company was founded by Martijn Rozemuller, Wietse Mulder, Oscar Schoots, and Raoul Linschoten in March 2005 and is headquartered in Utrecht, the Netherlands. | Directeur/Membre du Conseil | 01/08/2021 | - |
Historique de carrière de Bob van Gemen
Anciens postes connus de Bob van Gemen
Sociétés | Poste | Début | Fin |
---|---|---|---|
ViroClinics Biosciences BV
![]() ViroClinics Biosciences BV Pharmaceuticals: MajorHealth Technology ViroClinics Biosciences BV engages in the provision of diagnostic and clinical trial solutions. It offers research and development, preclinical, clinical trial operation, diagnostic testing, virus discovery, and quality assurance services. The company was founded by Albert Osterhaus in 2001 and is headquartered in Rotterdam, the Netherlands. | Directeur Général | 01/11/2011 | 01/08/2020 |
AKZO NOBEL N.V. | Corporate Officer/Principal | - | - |
PrimaGen Holding BV
![]() PrimaGen Holding BV Miscellaneous Commercial ServicesCommercial Services PrimaGen Holding BV designs and develops molecular diagnostic tests. The firm conducts tests in the fields of mitochondrial toxicity, drug development toxicology screening, HIV monitoring, DFS paper technology, oncology and virus discovery. It also develops in monitoring toxic side effects of antiviral medication and for diagnosing and monitoring certain forms of cancer. The company was founded in November 2001 and is headquartered in Amsterdam, the Netherlands. | Directeur Général | - | - |
Formation de Bob van Gemen
University of Leiden | Doctorate Degree |
Statistiques
Internationale
Pays-Bas | 6 |
Opérationnelle
Chief Executive Officer | 2 |
Corporate Officer/Principal | 1 |
Director/Board Member | 1 |
Sectorielle
Health Technology | 3 |
Commercial Services | 2 |
Process Industries | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
AKZO NOBEL N.V. | Process Industries |
Entreprise privées | 3 |
---|---|
PrimaGen Holding BV
![]() PrimaGen Holding BV Miscellaneous Commercial ServicesCommercial Services PrimaGen Holding BV designs and develops molecular diagnostic tests. The firm conducts tests in the fields of mitochondrial toxicity, drug development toxicology screening, HIV monitoring, DFS paper technology, oncology and virus discovery. It also develops in monitoring toxic side effects of antiviral medication and for diagnosing and monitoring certain forms of cancer. The company was founded in November 2001 and is headquartered in Amsterdam, the Netherlands. | Commercial Services |
ViroClinics Biosciences BV
![]() ViroClinics Biosciences BV Pharmaceuticals: MajorHealth Technology ViroClinics Biosciences BV engages in the provision of diagnostic and clinical trial solutions. It offers research and development, preclinical, clinical trial operation, diagnostic testing, virus discovery, and quality assurance services. The company was founded by Albert Osterhaus in 2001 and is headquartered in Rotterdam, the Netherlands. | Health Technology |
Genome Diagnostics BV
![]() Genome Diagnostics BV Medical SpecialtiesHealth Technology Genome Diagnostics BV develops and markets vitro diagnostic tests and services, analysis software & education. Its products include NGSengine, SBTexcellerator, AlleleSEQR and SBTengine. The company was founded by Martijn Rozemuller, Wietse Mulder, Oscar Schoots, and Raoul Linschoten in March 2005 and is headquartered in Utrecht, the Netherlands. | Health Technology |
- Bourse
- Insiders
- Bob van Gemen
- Expérience